Seeing Is Believing
Currently out of the existing stock ratings of Sachin Jain, 6 are a BUY (66.67%), 3 are a HOLD (33.33%).
Analyst Sachin Jain, currently employed at BAML, carries an average stock price target met ratio of 100% that have a potential upside of 30.13% achieved within 665 days. Previously, Sachin Jain worked at KEYBANK.
Sachin Jain’s has documented 13 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 06-Jun-2022.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/17/2020. The price target of $32.69 was fulfilled within 265 days with a profit of $5.15 (18.7%) receiving and performance score of 0.71.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 03-Jul-2023
3 months 4 days ago
(16-Oct-2025)
1/11 (9.09%)
$83.68 (135.40%)
2598
Buy
Since 27-Jan-2020
$87
$-7.39 (-7.83%)
$78
1 years 2 months 2 days ago
(18-Nov-2024)
9/9 (100%)
$24.91 (40.12%)
608
Buy
Since 05-Jan-2023
$88
$-6.39 (-6.77%)
$82
1 years 2 months 7 days ago
(13-Nov-2024)
5/5 (100%)
$24.05 (37.61%)
325
Buy
Since 01-Apr-2019
$95
$0.61 (0.65%)
$66
1 years 5 months 8 days ago
(12-Aug-2024)
7/7 (100%)
$14.17 (17.53%)
503
Buy
Since 29-Aug-2022
$85
$-9.39 (-9.95%)
$80
1 years 7 months 21 days ago
(30-May-2024)
4/4 (100%)
$10.26 (13.73%)
414
What Year was the first public recommendation made by Sachin Jain?